Tuberculosis diagnosis and monitoring rely in Sputum microscopy of National Tuberculosis Programme, Nepal because of its low cost and easier to perform. Direct sputum microscopy is popular worldwide. Currently, there are 533 microscopy centres catering for sputum microscopy examination throughout the country. Most of the microscopy centres are established within government jurisdiction and remaining are established as nongovernmental organization as well as private sectors. A cross-sectional study was conducted from July 2013 to January 2015. A total of 2091 patients were enrolled in the study who were attending the DOTS Centre in Parsa District of Public Health Office, Nepal. Smears stained with ZN stain methods were examined microscopically followed by the GeneXpert MTB/RIF assay. Out of 2091 suspected pulmonary TB patients enrolled for sputum microscopy and GeneXpert MTB/RIF for the confirmation of TB, the 1301(62.21%) were male and 790 (37.78%) were female. The maximum TB cases were from Parsa district (555, 26.5%). The comparative study of different diagnostic tools reveals the sensitivity of MTB/RIF was 95.50% (91.87, 97.82) and significantly higher than smear microscopy performed on the same fluid, which had a sensitivity of 61. 97% (55.41, 68.21). Five of 127 smear-negative cases had MTB/RIF-positive uncentrifuged sputum, resulting in a specificity of 81.23% (75.95, 85.78), which was similar to smear microscopy 98.29 % (97.34, 98.97; p=0.121). The positive predictive value (PPV) and negative predictive value (NPV) of MTB/RIF were 96. 85% (93.61, 98.72) and 94.95 % (93.52, 96.14), respectively. HIV co-infection did not impact sensitivity, specificity or liquid culture time to positivity (TTP). When MTB/RIF accuracy was evaluated using composite reference standard culture positivity from sputum, the sensitivity and specificity were similar to those obtained in the primary analysis using either definite TB versus possible and non-TB combined; definite and possible TB combined versus non-TB.
Introduction
Tuberculosis (TB) is a leading cause of death worldwide. In the early 1990s, the government of Nepal brought up a program to control TB at national scale called DOTS (Directly Observed Treatment Short Course) [1] . DOTS program was initiated in April 2001 with a goal to diagnose and cure TB patients which has treated more than 20 thousand patients till date [2] . Until December of 2014 there are 554 microscopy centres and 22 GenXpert location in the country which specializes in diagnosis of TB [3] . The expansion of DOTS program has proven its efficacy in reducing the mortality and morbidity in Nepal, however, despite of available diagnosis and treatment regimes, approximately 3000-5000 people are still dying per year of TB [4] . In a DOTS centre in Kathmandu, prevalence of Multi Drug Resistant (MDR) case of Tuberculosis was found to be 3.6% [5] , which could have been mitigated by early diagnosis and rapid identification of anti-TB agents resistance. Recent data from East Nepal suggests that 3.3% of all patients, who were smear microscopy negative, have RMP resistant TB [6] . Despite of DOTS and available diagnosis, complications due to MDR are emerging and also there hasn't been overall increment in number of people on anti tuberculosis treatment [6] . Sputum smear light microscopy, patients symptoms combined with CXR results is the preferred algorithm for TB diagnosis in Nepal. Smear test is neither relevant nor sensitive enough for the diagnosis of TB alone and needs additional diagnosis as well clinical suspecting to decide either patients should be enrolled on antibiotic or not [7] . 
Materials and Methods

Study sites and population
Patient classification and diagnosis algorithm
Specimen collection and laboratory procedures
Sputum specimens were processed using standardized protocols. The length of time between sample collection and results being issued to the clinic was also recorded. Smears stained with ZN stain methods were examined microscopically following the standard protocol. At least 200 fields were evaluated before reporting negative. Bacillary density was graded as scanty, 1+, 2+, and 3+, and all such smears were defined as ''smear-positive'. Following decontamination with N-acetyl-Lcysteine and sodium hydroxide, centrifuged sputum deposits underwent microscopy, and following re-suspension in phosphate buffer, equal volumes were tested by the GeneXpert MTB/RIF assay. The results of all tests were read by technologists blinded to the outcomes of the other assays. Sputum pellets were also tested by trained technologists using the GeneXpert MTB/RIF assay.
GeneXpert
MTB/RIF and patient management
The collected sputum sample was aliquoted in two equal volumes; first half for immediate primary clinical works and other for reference for future works at -20°C. From the first aliquot, the specimen was used for smear tests followed by GeneXpert MTB/RIF assay. The diagnostic assays were followed by a single specialized clinical research associate blind to the patient's diagnosis in ©NJB, Biotechnology Society of Nepalreference standard and index test, throughout the study period.
Statistical analysis
Collected data were analyzed and interpreted statistically using graphPad prism version 6.0 and SPSS 17.0. All the values are expressed as mean±SD and are analyzed using Student's t test which is parametric as well Mann-Whitney test wherever applicable. P value (P<0.05), was considered significant unless stated otherwise. The suspected pulmonary TB patients (n= 2091) were enrolled for sputum microscopy and GeneXpert MTB/RIF for the confirmation of TB. Among them, 1301(62.21%) were male and 790 (37.78%) were female. All the patients were referred to this centre by local doctors and physicians after having tuberculosis symptoms and abnormal chest radiograph for sputum microscopy and GeneXpert MTB/RIF for the confirmation of Makwanpur, Mahottari, Panchthar, Saptari, Siraha, Morang, Sindhuli, Rasuwa and Chitwan (Figure 1) . Since the study conducted at Parsa district, the actual number of case presented here does not highlight the prevalence of TB in the respective district. As Bara is the adjacent district to Parsa, the number of patients visited is more than other district. The prevalence of TB in Parsa district is 3 times higher than the prevalence in the Bara district. TB. The clinical symptoms showed most of the patients have fever, cough, and weight loss and night sweat ( Table 4) . The maximum TB cases were from Parsa district (555, 26.5%) followed by Bara, Rautahat, Sarlahi,
Results
Study population and TB diagnoses
Diagnostic accuracy of different method and MTB/RIF performed on uncentrifuged sputum
Direct sputum microscopy is popular worldwide. In Nepal, the Tuberculosis diagnosis and monitoring rely in Sputum microscopy because of its low cost and easier to perform. At present there are 533 microscopy centres catering the sputum microscopy examination throughout the country. The region wise distribution is given in Table 1 . Most of the microscopy centres are established in government setting and few are established in nongovernmental organization and private sectors. NTC-National Figure 2 and Figure 3 respectively. The comparative study of different diagnostic tools is given in Table 3 .
Of the 2091 patients enrolled in this study, the sensitivity of MTB/RIF was 95.50% (91.87, 97.82) and significantly higher than smear microscopy performed on the same fluid, which had a sensitivity of 61.97% (55.41, 68.21, Table 6 ) or TTP. When MTB/RIF accuracy was evaluated using composite reference standard culture positivity from sputum, the sensitivity and specificity were similar to those obtained in the primary analysis using either definite TB versus possible and non-TB combined; definite and possible TB combined versus non-TB.
Discussion
In Nepal, the estimated incidence of TB is 163 per 100,000 with a prevalence rate of 241 per 100,000 populations. In 2014-15, the Nepal Tuberculosis Programme (NTP) registered 17,788 sputum smearpositive cases and 8,367 sputum smear negative cases [6, 8] . A total of 2091 individuals from thirteen districts of Nepal were included in the present study and the prevalence of smear positive pulmonary tuberculosis was found to be 788 out of 2091(37.06 %). We found the most of the patients were passively participated in the study and almost all patients are visited Government hospital for the treatment. Approximately 66.76% of the patient had the cough duration for last 2 days. Although, only 37.09 % of patients had AFB positive on smear, out of which 97.8 % were new [9] , shows the GeneXpert MTB/RIF is a sensitive method for rapid diagnosis of Tuberculosis, especially in smear negative cases and in PTB as compared to the conventional ZN staining. For countries endemic for TB GeneXpert can serve as a sensitive and time saving diagnostic modality for pulmonary TB. Our study is consistent with other studies which have suggested the benefit of GeneXpert in smearnegative patients in developing countries [10, 11] .The majority of these studies have been carried out in Africa where there is a substantially higher HIV burden than in South Asia. Three studies have been reported from low-HIV prevalence regions, including Peru and two hospitals (Hinduja Hospital and Christian Medical College Hospital) in India [11, 12] . It is not clear how many of the patients testing positive for MTB by smear, culture and Gene Xpert in this study would have been started on TB treatment based on the judgement of the treating clinician if GeneXpert testing was not available. In the previous year (2013-2014) at Parsa district, 2245 patients were treated for TB, approximately onethird of those detected by GeneXpert during the study period. It is possible that the availability of GeneXpert increased the recognition of TB symptoms, although we can claim that in this endemic setting TB awareness is consistently high among clinicians. Conversely, it is possible that a negative smear test may have discouraged 15 .0 % which is consistent with the results in other areas of similar endemicity; it is therefore unlikely that the GeneXpert diagnosis was inflated due to low smear microscopy confirmation [13] [14] [15] .
If we look on test selection, smear microscopy, due to its simplicity, speed, and low cost, is used widely in low-resource settings; the low sensitivity precludes it from being an ideal test. The requirement for a rapid, simple TB diagnostic is evidenced by the widespread application of commercial serological tests which are inaccurate. These tests are widely provided at a cost to the patient and used to determine medical treatment.
Although the GeneXpert has several limitations, including requirement for stable electricity supply, limited temperature range, availability of maintenance, and bulky consumables, wider availability of the accurate GeneXpert assay may counter the use of these serological tests by providing a viable alternative to the patient and healthcare provider. It is highly probable that a small number of cases of TB were missed in this study as GeneXpert does not have as high sensitivity as culture. There is a danger that clinicians will "exclude" a TB diagnosis on the basis of a negative GeneXpert test and it is important that education is carried out to ensure clinicians are aware of the test limitations prior to the test being implemented. However, it is not sustainable to implement TB culture facilities at general hospitals in South Asia and the long turnaround of results means loss to follow-up in the diagnostic pathway is high. This study was not an assessment of GeneXpert sensitivity and specificity, as this has been comprehensively evaluated in comparison with culture by others.
Conclusion
The prevalence of TB is high in Parsa DOTS centre in comparable to other districts of Nepal. However, the relatively higher rate of RIF resistance observed in our study signals the danger of increasing MDRTB in the study areas in the future in Nepal.
On the other hand, MTB RIF positivity among sputum negative, RIF resistant (DR TB) among sputum negative and RIF resistant among retreatment cases is large in this study. The higher level of MDR-TB among previously treated patients suggests the need to strengthen the DOTS strategy and the capacity of laboratories to undertake effective treatment especially among previously treated patients in Nepal. The GeneXpet is more specific and sensitive that smear AFB detection. The Government of Nepal Ministry of Health and population should implement GeneXpert in each DOTS centre in Nepal for better diagnosis.
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